Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Immix Biopharma Closes $125 Million Stock Offering

Immix Biopharma Closes $125 Million Stock Offering

MT newswireMT newswire2026/09/30 21:36
05:36 PM EDT, 09/30/2026 (MT Newswires) -- Immix Biopharma (IMMX) closed its previously announced underwritten offering of 11.4 million common shares at $11 each, raising net proceeds of about $117.1 million, the company said Wednesday. The company plans to use the proceeds to fund development of NXC-201, working capital and general corporate purposes.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!